New Weight-Loss Drug's impact on coffee and common meds revealed

NCT ID NCT06564441

First seen Jan 11, 2026 · Last updated Apr 25, 2026 · Updated 15 times

Summary

This study looked at whether a new weight-loss injection (BI 456906) changes how the body processes three common drugs: bupropion (an antidepressant), caffeine, and midazolam (a sedative). Thirty-four healthy adults with overweight or obesity took these drugs alone and then again while receiving weekly injections of BI 456906. Researchers measured drug levels in the blood to see if there were interactions. The goal was to understand safe dosing for future use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • SGS Life Science Services - Clinical Research

    Edegem, 2650, Belgium

Conditions

Explore the condition pages connected to this study.